Go long in Lupin, Glenmark, Strides Shasun: SP Tulsian

SP Tulsian of sptulsian.com told CNBC-TV18, "I won’t be surprised to see pharma as the story for July series. The way I have given PSU bank story for June series, I won’t be hesitate in seeing a big upsurge happening in all big pharma names, whether that is Lupin. But if you really go by the trend, take the case of Aurobindo Pharma, Glenmark Pharma, Strides Shasun or maybe Wockhardt or maybe Lupin and even Sun Pharma for that matter.""We may need to see the buyback announcements which will be made from the company today, but I am taking a positive view on all these pharma biggies and those who have presence in F&O can really be outperformers for July series and that will be the theme for July F&O series for pharma stock. So, I am advising to go long in all these stocks," he said.